Subcontract to Tekmira: Dose Response Efficacy Study of TKM-100201 for the Treatment of Ebola Virus in Rhesus Macaques

Project: Other project

StatusFinished
Effective start/end date1/15/1212/31/12

Funding

  • Tekmira Pharmaceuticals Corporation: $235,335.00